NCT00939913 - Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Nephropathy

Interventions

DRUG

intravenous NAC

intravenous regimen of NAC (1,200 mg bolus followed by 200 mg/hour for 24 hours)

DRUG

Placebo

Study participants will be randomized to receive an intravenous regimen of NAC (1,200 mg bolus followed by 200 mg/hour for 24 hours) or placebo.

Trial Locations (1)

RECRUITING

Ochsner Medical Center, New Orleans